MEDICINOVA, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MEDICINOVA, INC. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $19.88M.
- MEDICINOVA, INC. stock issued during period, value, new issues for the quarter ending 2019-09-30 was $3.16M.
- MEDICINOVA, INC. stock issued during period, value, new issues for the quarter ending 2019-03-31 was -$8.53K, a 100.02% decline year-over-year.
- MEDICINOVA, INC. stock issued during period, value, new issues for the quarter ending 2018-12-31 was $0.00.
- MEDICINOVA, INC. stock issued during period, value, new issues for fiscal 2021 was $19.88M.
- MEDICINOVA, INC. stock issued during period, value, new issues for fiscal 2018 was $38.47M.
- MEDICINOVA, INC. stock issued during period, value, new issues for fiscal 2015 was $15.99M.
- MEDICINOVA, INC. stock issued during period, value, new issues for fiscal 2012 was $1.35M, a 30.90% decline from fiscal 2011.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2021-12-31 | $19.88M 10-K/A · filed 2023-03-28 | |
| 2021-03-31 | $19.88M 10-Q · filed 2022-11-10 | |
| 2019-09-30 | $3.16M 10-Q · filed 2020-10-26 | |
| 2019-03-31 | -$8.53K 10-Q · filed 2019-10-24 | -$34.92K derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $38.47M 10-K · filed 2020-02-13 |
| 2018-09-30 | -$7.93K 10-Q · filed 2019-10-24 | |
| 2018-06-30 | -$18.46K 10-Q · filed 2019-10-24 | |
| 2018-03-31 | $38.50M 10-Q · filed 2019-10-24 | |
| 2015-12-31 | $15.99M 10-K · filed 2018-02-13 | |
| 2012-12-31 | $1.35M 10-K · filed 2014-03-27 | |
| 2011-12-31 | $1.95M 10-K · filed 2013-03-28 | |
| 2007-12-31 | $10.64M 10-K · filed 2013-03-28 | |
| 2000-12-31 | $50.00K 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |